Irinotecan Hydrochloride Liposome Combined With Capecitabine and Lenvatinib in Patients With Biliary Tract Carcinoma

NCT06463548 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Biliary Tract Carcinoma

Interventions

DRUG: irinotecan hydrochloride liposome injection
DRUG: Capecitabine
DRUG: Lenvatinib

Sponsor

Yunpeng Liu

Collaborators

[object Object]